Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
285 hedge funds and large institutions have $6.15B invested in Syneos Health, Inc. Class A Common Stock in 2020 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 84 increasing their positions, 116 reducing their positions, and 32 closing their positions.
127% more call options, than puts
Call options by funds: $9.39M | Put options by funds: $4.14M
84% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 32
45% more capital invested
Capital invested by funds: $4.23B → $6.15B (+$1.92B)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
10% more funds holding
Funds holding: 260 → 285 (+25)
28% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 116
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$81.2M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$61M |
| 3 |
State Street
Boston,
Massachusetts
|
-$27.2M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$25.3M |
| 5 |
Goldman Sachs
New York
|
-$24.5M |
SYNH Hedge Fund Activity: Q2 2020 in Review
285 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q2 2020, worth a combined $6.15B — up 45% from $4.23B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new SYNH positions and 32 closed out — a net gain of 27 holders — while 84 added to existing stakes and 116 trimmed.
The largest buyer was Millennium Management, adding an estimated $53.9M. The largest seller was BlackRock, cutting an estimated $81.2M.
- 285 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q2 2020, up from 260 in Q1 2020.
- Funds reported $6.15B of Syneos Health, Inc. Class A Common Stock stock for Q2 2020, up 45% quarter-over-quarter.
- 59 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q2 2020 and 32 closed out, a net change of +27 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q2 2020 was Millennium Management, an estimated $53.9M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q2 2020 was BlackRock, an estimated $81.2M sold.
Based on aggregated 13F filings for Q2 2020.